Revision history of "Development of biopolymer nanoparticles for precise diagnosis and targeted prostate cancer therapy using radioisotopes" (Q107913)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 October 2024

  • curprev 18:0418:04, 9 October 2024DG Regio talk contribs 80,876 bytes +7 Changed label, description and/or aliases in pt
  • curprev 18:0418:04, 9 October 2024DG Regio talk contribs 80,869 bytes 0 Set a claim value: summary (P836): O tema do projeto é a realização de trabalhos de I & D para desenvolver um radiofármaco seguro e eficaz, constituído por nanopartículas marcadas com radioisótopos para terapias (diagnóstico conjunto e terapia) de cancro da próstata. Atualmente, este tipo de produto não é oferecido no mercado nacional, bem como no mercado europeu e nos EUA. Isto demonstra a elevada capacidade de inovação da solução desenvolvida. Tendo em conta o número crescente de c...

22 March 2024

15 January 2024

14 June 2023

12 June 2023

24 May 2023

2 March 2023

20 October 2022

2 July 2022

  • curprev 13:5713:57, 2 July 2022DG Regio talk contribs 77,670 bytes +49,224 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

18 January 2022

15 January 2022

17 December 2021

7 December 2021

1 December 2021

  • curprev 10:2910:29, 1 December 2021DG Regio talk contribs 17,410 bytes +2,648 Created claim: summary (P836): L’objectif du projet est d’effectuer des travaux de R & D afin de développer un produit radiopharmaceutique sûr et efficace composé de nanoparticules désignées par les radioisotopes pour la tanotique (diagnostic combiné et thérapie) du cancer de la prostate. À l’heure actuelle, ce type de produit n’est pas offert sur le marché intérieur, ni sur le marché européen ni aux États-Unis. Cela démontre la forte innovation de la solution en cours de dév...
  • curprev 10:2910:29, 1 December 2021DG Regio talk contribs 14,762 bytes +211 Changed label, description and/or aliases in fr: translated_label

29 October 2020

17 October 2020

  • curprev 17:1517:15, 17 October 2020DG Regio talk contribs 14,990 bytes +178 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 17:1517:15, 17 October 2020DG Regio talk contribs 14,812 bytes −177 Changed label, description and/or aliases in 1 language: remove_english_label
  • curprev 17:1517:15, 17 October 2020DG Regio talk contribs 14,989 bytes +2,418 Created claim: summary (P836): The subject of the project is to carry out R & D work to develop a safe and effective radiopharmaceutical, consisting of nanoparticles labelled with radioisotopes for therapies (joined diagnosis and therapy) of prostate cancer. Currently, this type of product is not offered on the domestic market as well as on the European market and in the USA. This demonstrates the high innovativeness of the developed solution. In view of the increasing number...
  • curprev 17:1517:15, 17 October 2020DG Regio talk contribs 12,571 bytes −1,891 Removed claim: summary (P836): The project involves the development of R & D for the development of a safe and effective radiopharmaceutical, consisting of nanoparticles based on prostate radioisotope (combined diagnosis and therapy) of prostate cancer. Currently, this product type is not offered on the domestic market, as well as at European and US level. This is evidenced by the highly innovative nature of the solution being developed. In view of the increasing number of...

24 September 2020

17 July 2020

22 June 2020

10 June 2020

6 June 2020

26 March 2020

9 March 2020

  • curprev 09:5809:58, 9 March 2020DG Regio talk contribs 12,740 bytes +1,891 Created claim: summary (P836): The project involves the development of R & D for the development of a safe and effective radiopharmaceutical, consisting of nanoparticles based on prostate radioisotope (combined diagnosis and therapy) of prostate cancer. Currently, this product type is not offered on the domestic market, as well as at European and US level. This is evidenced by the highly innovative nature of the solution being developed. In view of the increasing number of ca...

24 February 2020

18 February 2020

31 January 2020

14 January 2020